Showing results (291-300 of 5,003) with videos related to
Sort By:
Pageof 501
American Journal of Clinical Oncology|August 26, 2009
Low-dose iodine-131 metaiodobenzylguanidine therapy for patients with malignant pheochromocytoma and paraganglioma: single center experienceMark Shilkrut, Raquel Bar-Deroma, Gil Bar-Sela, et al.American Journal of Clinical Oncology|December 1, 1991
Human-human monoclonal antibody directed against tumor surface antigen in the treatment of human malignancy. A pilot studyK AlonsoAmerican Journal of Clinical Oncology|December 1, 1991
Regional hyperthermia in patients with recurrent genitourinary cancerZ Petrovich, B Emami, D Kapp, et al.American Journal of Clinical Oncology|December 1, 1991
High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology AssociationJ N Atkins, H B Muss, D Case, et al.American Journal of Clinical Oncology|January 1, 1991
Pharmacokinetics of droloxifene and its metabolites in breast cancer patientsH J Grill, K PollowAmerican Journal of Clinical Oncology|January 1, 1991
Structural requirements for the in vitro transformation of Syrian hamster embryo cells by stilbene estrogens and triphenylethylene-type antiestrogensM Metzler, D SchiffmannAmerican Journal of Clinical Oncology|January 1, 1991
Droloxifene, a new antiestrogen. Hormonal influences in postmenopausal breast cancer patientsS KvinnslandAmerican Journal of Clinical Oncology|January 1, 1991
Pharmacologic and biologic properties of droloxifene, a new antiestrogenU Eppenberger, K Wosikowski, W KüngAmerican Journal of Clinical Oncology|January 1, 1991
Droloxifene, a new antiestrogen, in advanced breast cancer. A double-blind dose-finding study. The Droloxifene 002 International Study GroupL DeschênesAmerican Journal of Clinical Oncology|September 5, 2009
A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancerChong Kun Im, Sun Young Rha, Hei-Cheul Jeung, et al.Pageof 501